ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,615
-0,33%
Bitcoin
60 216,71
-0,63%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) Actualités

WINT Windtree Therapeutics Inc

5,00
-0,30 (-5,66%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Windtree Therapeutics Inc WINT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,30 -5,66% 5,00 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,38 5,02 5,38 5,065 5,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202414:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17/4/202414:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
08/4/202422:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
16/2/202423:07EDGAR2Form 8-K - Current report
14/2/202423:23EDGAR2Form S-3 - Registration statement under Securities Act of..
14/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
01/2/202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202414:00GLOBEWindtree Renews Agreement with Chang Gung University for..
31/1/202414:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
31/1/202414:00EDGAR2Form 8-K - Current report
31/1/202414:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
25/1/202415:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
25/1/202414:34EDGAR2Form 8-K - Current report
25/1/202414:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
22/1/202422:45EDGAR2Form 8-K - Current report
17/1/202414:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
17/1/202413:56EDGAR2Form 8-K - Current report
16/1/202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/1/202422:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
18/12/202314:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
16/11/202314:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
13/11/202317:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/11/202322:21EDGAR2Form 8-K - Current report
09/11/202322:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
09/11/202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202314:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
12/10/202313:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10/10/202313:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
03/10/202314:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
28/9/202313:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202313:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:48EDGAR2Form 8-K - Current report
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
06/9/202301:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:15EDGAR2Form 8-K - Current report
26/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202314:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
16/8/202323:19EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
07/8/202322:02EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
WINT
Windtree Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés